FORTIS Fortis Healthcare Q1 FY26 results (Apr–Jun 2025) and concall
Fortis Healthcare delivered a strong Q1 FY26 performance, marked by robust revenue and EBITDA growth across both hospital and diagnostics segments. Strategic acquisitions and O&M agreements expanded the company's operational footprint, while internal initiatives like improved case mix and digital adoption drove profitability. The quarter saw an increase in net debt due to funding these growth initiatives.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 357 | 367 | 388 | 433 |
| EBITDA | 60 | 67 | 71 | 88 |
| Net profit | 40 | 40 | -42 | 52 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
